New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
07:08 EDTABAX, IDXX, VIVO, EXAS, QDEL, DGXLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.
News For IDXX;DGX;EXAS;ABAX;QDEL;VIVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
10:01 EDTABAX, IDXXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AT&T (T) initiated with a Buy at DA Davidson... Abaxis (ABAX) initiated with an Underperform at Credit Suisse... Aratana Therapeutics (PETX) initiated with an Outperform at Credit Suisse... Care.com (CRCM) initiated with an Equal Weight at Morgan Stanley... GCP Applied Technologies (GCP) initiated with a Buy at Jefferies... Heritage-Crystal Clean (HCCI) initiated with a Buy at Roth Capital... IDEXX (IDXX) initiated with an Outperform at Credit Suisse... Nexvet Biopharma (NVET) initiated with an Outperform at Credit Suisse... PetMed Express (PETS) initiated with an Underperform at Credit Suisse... Phibro Animal Health (PAHC) initiated with an Outperform at Credit Suisse... Pure Storage (PSTG) initiated with a Perform at Oppenheimer... SeaWorld (SEAS) initiated with a Neutral at Janney Capital... Seattle Genetics (SGEN) initiated with an Overweight at Barclays... VCA Inc. (WOOF) initiated with an Outperform at Credit Suisse... Verizon (VZ) initiated with a Neutral at DA Davidson... Zoetis (ZTS) initiated with an Outperform at Credit Suisse.
07:44 EDTABAXAbaxis initiated with an Underperform at Credit Suisse
Credit Suisse analyst Erin Wilson initiated Abaxis with an Unperform rating and $39 price target on shares. Wilson sees slowing growth, increasing competition, and reduced contributions from new distribution relationships pressuring earnings growth.
07:42 EDTIDXXIDEXX initiated with an Outperform at Credit Suisse
Subscribe for More Information
January 29, 2016
07:07 EDTIDXXIDEXX sees FY16 EPS $2.10-$2.17, consensus $2.13
Sees FY16 revenue $1.69B-$1.71B, consensus $1.71B. Sees FY16 free cash flow to be 95%-100% of net income. Sees FY16 CapEx $90M. Sees FY16 operating margin to be 18%-18.5%, or approximately 100 basis points below 2015 adjusted operating margin levels, driven by ForEx impacts including comparisons to benefits from 2015 hedge gains. Sees FY16 effective tax rate of 30%-30.5%.
07:05 EDTIDXXIDEXX reports Q4 normalized organic revenue growth up 11%
Subscribe for More Information
07:05 EDTIDXXIDEXX reports Q4 adjusted EPS 48c, consensus 44c
Reports Q4 revenue $399.69M, consensus $396.99M.
January 28, 2016
16:04 EDTABAXAbaxis reports Q3 EPS 35c, consensus 33c
Subscribe for More Information
06:49 EDTDGXQuest Diagnostics raises quarterly dividend to 40c per share from 38c per share
Quest Diagnostics' board authorized a 5% increase in its quarterly dividend from 38c to 40c per share, or $1.60 per share annually, payable on April 20, to shareholders of record of Quest Diagnostics common stock on April 6.
06:48 EDTDGXQuest Diagnostics sees FY16 adjusted EPS $5.02-$5.17, consensus $5.09
Sees FY16 revenue $7.52B-$7.59B, consensus $7.58B.
06:47 EDTDGXQuest Diagnostics reports Q4 adjusted EPS $1.19, consensus $1.19
Reports Q4 revenue $1.85B, consensus $1.85B.
January 27, 2016
07:33 EDTVIVOMeridian Bioscience backs FY16 EPS view of 86c-90c, consensus 88c
Backs FY16 revenue guidance of $195M-$200M, consensus $197.86M.
07:32 EDTVIVOMeridian Bioscience reports Q1 EPS 21c, consensus 21c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use